NCT01455389 2022-03-02TUSC2-nanoparticles and Erlotinib in Stage IV Lung CancerGenprex, Inc.Phase 1/2 Terminated25 enrolled
NCT00226941 2017-12-08A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal CancerStanford UniversityPhase 1/2 Terminated23 enrolled 18 charts